Enavant XIMSIBO Rifaximin Tablets for Dogs | Gut Antibiotic for SIBO, HE & Traveller's Diarrhoea | 10 x 10 Tablets

Enavant XIMSIBO contains Rifaximin IP, a minimally absorbed, gut-selective antibiotic specifically formulated for use in dogs. Available in 200mg and 400mg strengths, XIMSIBO targets pathogenic gut bacteria responsible for Small Intestinal Bacterial Overgrowth (SIBO), Hepatic Encephalopathy (HE), and acute infective diarrhoea, with minimal systemic absorption ensuring high local concentration and reduced risk of systemic side effects.

Rx. Schedule H Prescription Drug - Caution: Not to be sold by retail without the prescription of a Registered Veterinary Practitioner. For use in dogs only. Not for human use. Keep out of reach of children.

Composition

• XIMSIBO-200: Rifaximin IP 200mg per tablet
• XIMSIBO-400: Rifaximin IP 400mg per tablet

Key Features

• Gut-selective antibiotic — acts locally in the GI tract with minimal systemic absorption
• Broad-spectrum activity against gram-positive and gram-negative gut pathogens
• Reduces ammonia-producing bacteria — key mechanism in managing Hepatic Encephalopathy
• Helps restore normal gut flora balance in SIBO
• Low risk of systemic side effects compared to conventional antibiotics
• Available in two strengths for weight-based dosing flexibility
• Pack: 10 x 10 tablets (100 tablets per box)

Indications

• Small Intestinal Bacterial Overgrowth (SIBO) in dogs
• Hepatic Encephalopathy (HE) — reduction of ammonia-producing gut bacteria
• Acute infective and traveller’s diarrhoea
• Irritable Bowel Syndrome (IBS) with gut dysbiosis
• Post-antibiotic gut flora restoration

Dosage

As directed by a Registered Veterinary Practitioner based on body weight, indication, and duration of therapy.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.